Last reviewed · How we verify
NCT04605315
Indications and Outcomes in Kidney-ureteral Pediatric Lithiasis: Experience of Parma
trial in Pediatric ALL in 70 participants. Completed in 31 August 2019.
31 August 2019
Quick facts
| Lead sponsor | Azienda Ospedaliero-Universitaria di Parma |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 70 |
| Start date | 1 July 2019 |
| Primary completion | 31 August 2019 |
| Estimated completion | 31 August 2019 |
| Sites | 1 location across Italy |
Conditions studied
- Pediatric ALL — all drugs for Pediatric ALL →
- Stone, Urinary — all drugs for Stone, Urinary →
Sponsor
Azienda Ospedaliero-Universitaria di Parma — full company profile →
Who can join
Adults 0 to 17, any sex, with Pediatric ALL or Stone, Urinary. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Incidence of paediatric urolithiasis is increasing in Europe and North America. Nowadays the management of stone disease is a common practice in not endemic country. The surgical's treatment is based on similar techniques as for adults. In the last years due to miniaturization of endoscopic instruments endourology has become the best approach to treat urinary stones in children. The investigators have retrospectively reviewed experience from 01/01/2000 to 28/02/2019 in children ≤ 16 years old affected by urinary stones who underwent rigid and flexible ureterorenoscopy and pecutaneous nephrolitotripsy procedures and recorded clinical data, overall success rate and complication.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT04605315
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Pediatric ALL
Currently open trials in the same condition.
- NCT07059624 — Femoral Arterial Cannulation in Pediatrics · NA · recruiting
- NCT06867289 — Study of the Efficacy of Moderate Sedation With Intra-NAsal Dexmedetomidine Monitored by EEG MOnitoring · NA · recruiting
- NCT06325280 — Exercise MRI to Evaluate Cardiorespiratory Fitness in Children With Heart Disease · recruiting
- NCT06274788 — Safety Study to Evaluate the Occurrence of EFAD in Pediatric Patients With PNAC Who Require More Than Eight Weeks of Ome · recruiting
- NCT06096272 — Using Augmented Reality to Promote Physical Activity in Children With Cerebral Palsy · NA · recruiting
Other Azienda Ospedaliero-Universitaria di Parma trials
Trials by the same sponsor.
- NCT07360366 — Interprofessional Collaboration in the Cardiac Intensive Care Unit (CICU): An Action-Research Training Project · NA · not yet recruiting
- NCT06888167 — Food (Poly)Phenol Metabotypes and Beta-cell Mass and Function. · NA · recruiting
- NCT06876818 — Predictive Cardio-Metabolic Trascrictomics Trajectories In The Barilla Offspring Follow-Up Study · active not recruiting
- NCT07419178 — A New Diagnostic Algorithm to Non-invasively Track Fibrotic Changes in Myeloproliferative Neoplasms Based on C-C Chemoki · NA · recruiting
- NCT05936944 — Role of Natural Light in the Prevention of Delirium After Cardiac Surgery: a Prospective Observational Study With Histor · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04605315 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Azienda Ospedaliero-Universitaria di Parma
- Last refreshed: 30 October 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04605315.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing